Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-016881
Filing Date
2024-01-26
Accepted
2024-01-26 17:25:57
Documents
9
Effectiveness Date
2024-01-26

Document Format Files

Seq Description Document Type Size
1 S-8 d746958ds8.htm S-8 60066
2 EX-5.1 d746958dex51.htm EX-5.1 6949
3 EX-10.1 d746958dex101.htm EX-10.1 204570
4 EX-10.2 d746958dex102.htm EX-10.2 322449
5 EX-10.3 d746958dex103.htm EX-10.3 234672
6 EX-10.4 d746958dex104.htm EX-10.4 102242
7 EX-23.1 d746958dex231.htm EX-23.1 1983
8 EX-FILING FEES d746958dexfilingfees.htm EX-FILING FEES 31607
9 GRAPHIC g746958g0127011806392.jpg GRAPHIC 2373
  Complete submission text file 0001193125-24-016881.txt   969052
Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Filer) CIK: 0001991792 (see all company filings)

EIN.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276729 | Film No.: 24569188
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)